U.S. Preventive Services Task Force Recommendation on PSA Testing - Resource Center
The United States Preventative Services Task Force (USPSTF) made a final recommendation on May 21, 2012 which aligned consistently with the draft recommendation publicly announced on October 7, 2011.
The recommendation is against prostate-specific antigen (PSA) based screening for healthy men, asserting that there is “moderate or high certainty that the service has no benefit or that the harms outweigh the benefits,” discouraged the use of the test by issuing it a Grade D rating. The D rating applies to men of all ages but does not apply to the use of PSA testing for monitoring patients after a prostate cancer diagnosis or treatment.
For scientific background and references, please click here.
Why Prostate Cancer Screening Is So Tricky (2/06/2013)
New Jersey Leads the Nation in Opposing USPSTF PSA Testing Recommendation | Governor Chris Christie Signs Resolution Passed Unanimously by Legislature (1/17/2012)
U.S. Health and Human Services Will Continue Medicare Coverage for PSA Testing. Read the letter to PCF from HHS Secretary, Kathleen Sebelius. (12/19/2011)
Death by Bureaucracy | Newt Gingrich discusses the dubious credibility of the USPSTF and government interference with personal medical decisions. (10/19/2011)
New Urine DNA Test Used with PSA Can Eliminate Unnecessary Biopsies and Reduce Fear of Overtreatment | Detecting Two Cancer-Specific Genetic Fingerprints Can Better Direct Patients and Eliminate Unnecessary Prostate Biopsies. (10/11/2011)
The USPSTF will be accepting comments on this draft recommendation beginning on Tuesday, October 11, 2011. Due to technical errors, the submission deadline has been extended to Tuesday, December 13, 2011. This is your opportunity to weigh in on what questions researchers focus on when reviewing the evidence and comment on the Effective Health Care (EHC) Program research reports that are related to the recommendation.
The Prostate Caner Foundation hopes you will take the time to comment here.
If you need more information regarding how USPSTF recommendations are drafted, please visit here.
Reaching Beyond the PSA Debate | An update from Dr. Jonathan Simons, the President and CEO of the Prostate Cancer Foundation
Prostate Cancer Screening: Think Different | Read a reasoned opinion piece from PCF-supported investigators Matthew Cooperberg, MD, MPH, Dean Ornish, MD and Peter Carroll, MD, MPH stating that the solution to PSA screening is to “screen smarter and treat better.” (6/12/2012)
Dana-Farber Expert: The 'Wrong Message' About Prostate Screening | Dr. Philip Kantoff speaks out against the USPSTF recommendation. (10/13/2011)
Treating or Ignoring Prostate Cancer [AUDIO] | WAMU 88.5 broadcasts an NPR interview with Dr. Patrick Walsh, Dr. Gerald Andriole, Dr. Chiledum Ahaghotu and Shannon Brownlee where they evaluate the risks and benefits of PSA screenings. Read the full transcript here. (10/11/2011)
A Perfect Storm: PSA Screening is Imperfect But Not Failed | On his blog My New York Minute, Dan Zenka argues that the PSA Test is not a failed test.(5/22/2012)